Government Affairs
Refine Search
Biotechnology
The UK government has announced a £1.25 billion ($1.56 billion) support package for innovative businesses during the coronavirus outbreak. 21 April 2020
Pharmaceutical
A new Vaccine Taskforce will drive forward, expedite and coordinate efforts to research and then produce a coronavirus vaccine, according to a statement issued by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). 20 April 2020
Pharmaceutical
The Russian government and representatives of some of leading drugmakers operating in the local market have confirmed they will ensure uninterrupted supplies of drugs and vaccines against COVID-19 to Russia, in anticipation of a significant increase on the number of people infected with coronavirus, according to recent statements by representatives of producers, reports The Pharma Letter’s local correspondent. 15 April 2020
Pharmaceutical
The Association of International Pharmaceutical Manufacturers (AIPM), uniting more than 60 leading world pharmaceutical companies in Russia, says it is doing everything possible to coordinate the efforts of the industry and support the state in combating the COVID-19 pandemic. 13 April 2020
Pharmaceutical
As part of the UK government’s announcement of a new five pillar plan to increase testing for COVID-19, French clinical diagnostics company Novacyt is collaborating with AstraZeneca, GlaxoSmithKline and the University of Cambridge to take action to support this national effort. 8 April 2020
Pharmaceutical
After US President Donald Trump hinted at retaliatory measures, India is to export the anti-malarial drug hydroxychloroquine (HCQ) to some countries. 7 April 2020
Generics
As China’s active pharmaceutical ingredient (APIs) makers restart operations, the first consignment of raw materials has already touched Indian shores. Imports from all Chinese provinces, barring one, have commenced to India, with supplies expected to buck up in the coming weeks, reports The Pharma Letter’s India correspondent. 1 April 2020
Generics
The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund specializing in equity investments in the high-tech sector, together with the local drugmaker ChemRar Group, will start the production of a new drug designed for treatment of COVID-19, according to the companies, reports The Pharma Letter’s local correspondent. 31 March 2020
Pharmaceutical
Grifols has formidable partners in its drive to produce what it calls the ‘first treatment specifically targeting COVID-19. 27 March 2020
Generics
India’s Department of Pharmaceuticals (DoP) has proposed an incentive scheme worth around 10,000 billion rupees ($1.3 billion) aiming to strengthen the domestic active pharmaceutical ingredients (APIs) facilites to boost domestic manufacturing in India to compensate for dwindling Chinese supply because of the coronavirus outbreak. 26 March 2020
Pharmaceutical
The Russian government has approved a package of measures aimed at ensuring regular supplies of drugs and avoiding their shortages in the domestic market this year, according to recent statements by an official spokesman of state press-service and some local media, reports The Pharma Letter’s local correspondent. 24 March 2020
Biotechnology
The UK BioIndustry Association (BIA) has welcomed revised proposals put forward by the government to ensure that genuine biotech companies are not penalised by a cap on R&D tax credits. 20 March 2020
Pharmaceutical
The US Prescription Drug Pricing Reduction Act introduced by Senators Charles Grassley (Republican, Iowa) and Ron Wyden (Democrat, Oregon) could generate over $94 billion in savings over the next decade if enacted, according to an analysis from the Congressional Budget Office. 19 March 2020
Pharmaceutical
New money from the UK’s Department of Health and Social Care will ensure “anyone who is at a high risk of contracting HIV will receive PrEP from their local sexual health clinic,” the British Government announced on Sunday. 16 March 2020
Generics
Medicines for Europe, the generics trade association, has made three requests as it attempts to ensure continued drug supply apply across the continent amid the ongoing COVID-19 outbreak. 13 March 2020
Pharmaceutical
Presenting his first Budget today, Britain’s Chancellor of the Exchequer Rishi Sunak announced that research and development investment will be increased by £22 billion ($28.6 billion), making it the fastest and biggest R&D ever R&D spend. 11 March 2020
Pharmaceutical
Leading Russian drugmakers and foreign companies operating in the local market have called on the Russian government to change the existing rules for public procurements of drugs in Russia. 10 March 2020
Pharmaceutical
In response to a sharp price increase in the domestic market caused by the spread of the novel coronavirus (COVID-19), the Russian government and the national Parliament (State Duma) are considering introducing state regulation over prices for drugs and medical devices in the domestic market 10 March 2020
Biotechnology
The UK BioIndustry Association (BIA) has called for entrepreneurs and innovative small and medium-sized enterprises (SMEs) to be supported in the upcoming Budget. 9 March 2020
Pharmaceutical
The US House of Representatives and Senate on Wednesday and Thursday passed an $8.3 billion emergency funding package, which dwarfs the $2.5 billion request by the White House, and it was signed off by President Donald Trump on Friday morning. 6 March 2020
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze